<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150503022068N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-09-27</date_registration>
      <primary_sponsor>Kharazmi University</primary_sponsor>
      <public_title>The effects of online pain education interventionon pain, disability, psychological factors and function in participants with chronic non-specific neck pain</public_title>
      <acronym></acronym>
      <scientific_title>The comparison between the effects of online pain education interventions with online and face to face  exercise on pain, disability, psychological factors and function in participants with chronic non-specific neck pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/58943</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants are randomized into two active treatment groups and one passive control group, by drawing a number, from 1 to 120, prepared in advance by the trainer and placed in sealed envelopes in a box, Blinding description: Assessor data analyzer were blinded to group allocation. participants were not blinded to exercise study however they were not aware which treatment was considered to be therapeutic.</study_design>
      <phase>N/A</phase>
      <hc_freetext>chronic none specific neck pain.</hc_freetext>
      <i_freetext>Intervention group: For all participants in the two experimental groups, 3 introductory sessions will be held to teach pain management approaches as well as how to perform the exercises over a period of approximately three months. In this study, 3 training sessions will be held in 2 weeks, which will be conducted by the researcher. The schedule is the same for all three treatment groups. The first session will be a group session (duration 30 minutes to an hour) with a maximum of 6 participants in each group, led by a researcher using a PowerPoint presentation. Participants will then be asked to read an instruction booklet containing the same information at home. The second session is home-based online e-learning, which includes 3 explanatory videos. These videos explain the same PowerPoint that was shown during the first session along with its screening. Therefore, in the second session, which is held online, the same issue discussed in the first group session will be explained again. After each clip, participants are asked to complete a questionnaire that will assess their understanding and opinion of the film. The third session will include a 30-minute one-on-one conversation focusing on patients' personal needs: The questions in the second session questionnaire will be analyzed. And how to use this information in the patient's daily life is discussed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only part of the data, such as the dependent variables,
The average of all samples, can be shared in scientific
articles.

When:
Access period starts 6 months after the results are published

To whom:
Personal information is confidential and general results
are available to anyone in the article

Conditions:
Information is not available to anyone. general results
are available to anyone in the article

Where to obtain:
Zohreh Khosrokiani; 00989112133552- Email:zohreh.khosrokiani@khu.ac.ir

How to obtain:
Zohreh Khosrokiani; 00989112133552- Email:zohreh.khosrokiani@khu.ac.ir

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zohreh Khosrokiani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Center for Human Movement Sciences Kharazmi University Mirdamad, Sout Razan Street, Hesari Street, Keshvari Sport Complex, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15447-33111</zip>
        <telephone>+98 21 2222 8001</telephone>
        <email>zohreh.khosrokiani@khu.ac.ir</email>
        <affiliation>Kharazmi University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zohreh Khosrokiani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Center for Human Movement Sciences Kharazmi University Mirdamad, Sout Razan Street, Hesari Street, Keshvari Sport Complex, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15447-33111</zip>
        <telephone>+98 21 2222 8001</telephone>
        <email>zohreh.khosrokiani@khu.ac.ir</email>
        <affiliation>Kharazmi University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Men and women 18-65 years.
VAS scale &lt;3 in these individuals.
Minimum history of neck pain 12 weeks and three days a week.
Go to medical centers to treat neck pain.
Do not start treatment or take medication</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnancy.
Dissatisfaction with participating in the research
Lack of regular participation in training sessions
People with spinal osteoporosis.
People with a history of spinal tumors
Participate in exercise therapy courses to treat neck pain in the last three years.
Having criteria for referral to surgery such as severe cervical vertebral discopathy.
Having any fractures and surgery in the cervical spine in the last three years.
In case of injury during the interventions</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>neck pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: For all participants in the two experimental groups, 3 introductory sessions will be held to teach pain management approaches as well as how to perform the exercises over a period of approximately three months. In this study, 3 training sessions will be held in 2 weeks, which will be conducted by the researcher. The schedule is the same for all three treatment groups. The first session will be a group session (duration 30 minutes to an hour) with a maximum of 6 participants in each group, led by a researcher using a PowerPoint presentation. Participants will then be asked to read an instruction booklet containing the same information at home. The second session is home-based online e-learning, which includes 3 explanatory videos. These videos explain the same PowerPoint that was shown during the first session along with its screening. Therefore, in the second session, which is held online, the same issue discussed in the first group session will be explained again. After each clip, participants are asked to complete a questionnaire that will assess their understanding and opinion of the film. The third session will include a 30-minute one-on-one conversation focusing on patients' personal needs: The questions in the second session questionnaire will be analyzed. And how to use this information in the patient's daily life is discussed</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The effects of online pain education interventions with online and face to face  exercise on pain in participants with chronic non-specific neck pain between 3 and 7 using Numerical Rating Scale. Timepoint: Measurement of pain at the beginning of the study and after three months of exercise. Method of measurement: Numerical Rating Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The effetcs of online pain education interventions with online and face to face  exercise on pain, disability, psychological factors and function in participants with chronic non-specific neck pain. Timepoint: The effects of online pain education interventions with online and face to face  exercise on pain, disability, psychological factors and function in participants with chronic non-specific neck pain before and after three months of interventions. Method of measurement: Comparison of the effects of online training of pain interventions with online and face-to-face exercises on pain, disability, psychological factors and performance in people with chronic nonspecific neck before and after three months of training using pain rating scale, neck disability index, Depression, Anxiety and Stress Scale -21  And after three exercises.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kharazmi University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-07-11</approval_date>
        <contact_name>Ethic committee of Kharazmi University of Medical Science (IR.KHU.REC.1400.013).</contact_name>
        <contact_address>postal code 4714744751, Isar 1 ded end, 17 Meraj St., Khorshid KolaT Babol Babol Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
